BCR and neoplasm: Fourth, GSEA revealed the downregulation of genes for multiple pathways in plasma cells from tumours at the advanced stages, including BCR signalling, peptide biosynthetic process, and protein transport (Fig. 2f), which suggest decreased antibody production of plasma cells.